Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Lucy R. Yates
Based on 11 articles published since 2009
(Why 11 articles?)
||||
Expertise Level
The expertise of Lucy R. Yates ranks in the
  • Top 0.46%
  • ... of 287,191 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 11 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Yates, Lucy   ·   Yates, Lucy R
Work Locations
Details
Most likely:    Wellcome Trust Sanger Institute      
2017
  • Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom. · Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London, United Kingdom. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 28572257
  • Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Big Data Institute, University of Oxford, Oxford OX3 7BN, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; European Bioinformatics Institute EMBL-EBI, Wellcome Genome Campus, Hinxton CB10 1SD, UK. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, USA; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, NM 87545, USA; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87102, USA. · The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Department of Human Genetics, University of Leuven, 3000 Leuven, Belgium. · Department of Pathology, Haukeland University Hospital, Bergen, Norway; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Computational Oncology, Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Institute, New York, NY 10065 USA. · Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK. · Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, 1000 Brussels, Belgium. · Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Department of Medical Oncology, Rotterdam, the Netherlands. · Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA; Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK; Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. Electronic address: · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. Electronic address: · Pubmed 28810143
  • Wellcome Trust Sanger Institute, Hinxton, UK. · Guy's and St Thomas' NHS Trust, London, UK. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. · Oncology, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Little Chesterford, UK. · Translational Research Lab Department, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics, Erasmus University Medical Center, Rotterdam, the Netherlands. · Centre for Clinical Research and School of Medicine, The University of Queensland, Brisbane, Queensland, Australia. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Department of Pathology, College of Medicine, Hanyang University, Seoul, Republic of Korea. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, UK. · Department of Molecular Biology, Faculties of Science and Medicine, Radboud University, Nijmegen, the Netherlands. · Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands. · Department of Cancer Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. · Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands. · Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. · Department of Pathology, Institut Curie, Paris, France. · INSERM U934, Institut Curie, Paris, France. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Now Research Unit, King's College, London, UK. · Breast Cancer Now Toby Robin's Research Centre, Institute of Cancer Research, London, UK. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · HistoGeneX, Wilrijk, Belgium. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, Montbonnot-Saint Martin, France. · Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Pubmed 28288110
2016
  • J.-C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000, Brussels, Belgium. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, UK. · 2nd Department of Pathology, Semmelweis University, Budapest, Hungary. · Pubmed 26951551
  • Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA. · Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Department of Human Genetics, University of Leuven, B-3000 Leuven, Belgium. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands. · Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA Nijmegen, The Netherlands. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway. · K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway. · Department of Computer Science, University of Oslo, Oslo, Norway. · Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea. · Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373 Lyon Cedex 08, France. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000 Brussels, Belgium. · Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea. · Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas 77030, USA. · Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea. · Institut National du Cancer, Research Division, Clinical Research Department, 52 avenue Morizet, 92513 Boulogne-Billancourt, France. · University Hospital of Minjoz, INSERM UMR 1098, Bd Fleming, Besançon 25000, France. · Pathology Department, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. · Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France. · The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland 4029, Australia. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. · IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373 Lyon Cédex 08, France. · Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Institut Curie, Paris Sciences Lettres University, Department of Pathology and INSERM U934, 26 rue d'Ulm, 75248 Paris Cedex 05, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK. · Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London SW3 6JB, UK. · Department of Clinical Science, University of Bergen, 5020 Bergen, Norway. · Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway. · National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore. · Singapore General Hospital, Outram Road, 169608, Singapore. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655, Avenue de l'Europe, 38330 Montbonnot-Saint Martin, France. · Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France. · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas 77230, USA. · Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland 4029, Australia. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA. · Pubmed 27135926
2015
  • 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. [2] Department of Oncology, The University of Cambridge, Cambridge, UK. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. · 1] Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway. [2] Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. [2] Department of Human Genetics, University of Leuven, Leuven, Belgium. · Department of Surgery, Haukeland University Hospital, Bergen, Norway. · 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. [2] Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA. · Department of Pathology, Haukeland University Hospital, Bergen, Norway. · 1] Department of Pathology, Haukeland University Hospital, Bergen, Norway. [2] The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · 1] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 26099045
  • Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom; · Cytogenetics Facility, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom; · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, United Kingdom; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, United Kingdom; · Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, United Kingdom; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, United Kingdom; · Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, United Kingdom; Cancer Research UK (CRUK) Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom; · BioCare, Strategic Cancer Research Program, SE-223 81 Lund, Sweden; CREATE Health, Strategic Centre for Translational Cancer Research, SE-221 00 Lund, Sweden; Department of Oncology and Pathology, Lund University Cancer Center, SE-221 85 Lund, Sweden; · Breakthrough Breast Cancer Research Unit, Research Oncology, King's College London, Guy's Hospital, London SE1 9RT, United Kingdom; · Laboratory for International Alliance on Genomic Research, RIKEN Center for Integrative Medical Sciences, 230-0045 Yokohama, Japan; National Center for Genome Medicine, Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan; · Department of Laboratory Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California 94158, USA; Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands; · Department of General Surgery, Singapore General Hospital, Singapore 169608; · Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver V5Z 1L3, Canada; · Department of Radiation Oncology and Department of Laboratory Medicine, Radboud University Medical Center, 6525 HP Nijmegen, Netherlands; · Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 CE Rotterdam, Netherlands; · Section of Oncology, Department of Clinical Science, University of Bergen, N-5020 Bergen, Norway; Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway; · Institut Curie, INSERM U934 and Department of Tumor Biology, 75248 Paris cédex 05, France; · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, 0450 Oslo, Norway; · Cancer Research Laboratory, University of Iceland, 101 Reykjavik, Iceland; · Royal National Orthopaedic Hospital, Middlesex HA7 4LP, United Kingdom; UCL Cancer Institute, University College London, London WC1E 6DD, United Kingdom; · University of Liverpool and HCA Pathology Laboratories, London WC1E 6JA, United Kingdom; · Urological Research Laboratory, Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, United Kingdom; Department of Surgical Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; · Institute of Cancer Research, Sutton, London SM2 5NG, United Kingdom; Department of Biological Sciences and School of Medicine, University of East Anglia, Norwich NR4 7TJ, United Kingdom; · Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton SM2 5NG, United Kingdom; Royal Marsden NHS Foundation Trust, London SW3 6JJ and Sutton SM2 5PT, United Kingdom; · University of Queensland, School of Medicine, Brisbane, QLD 4006, Australia; Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, QLD 4029, Australia; University of Queensland, UQ Centre for Clinical Research, Brisbane, QLD 4029, Australia; · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, 1000 Brussels, Belgium; · Université Lyon 1, Institut National du Cancer (INCa)-Synergie, 69008 Lyon, France; · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA; · Department of Pathology, Ninewells Hospital and Medical School, Dundee DD1 9SY, United Kingdom; · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 25963125
2014
  • Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK. · Department of Physiology, School of Medicine-Center for Resesarch in Molecular Medicine and Chronic Diseases, Instituto de Investigaciones Sanitarias, University of Santiago de Compostela, Spain. · Lungs for Living Research Centre, Rayne Institute, University College London (UCL), London, UK. · Department of Clinical Science, University of Bergen, Bergen, Norway. · Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Human Genome Laboratory, Department of Human Genetics, VIB and KU Leuven, Leuven, Belgium. · Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Haematology, University of Cambridge, Cambridge, UK. · University of Liverpool and HCA Pathology Laboratories, London, UK. · Cancer Research UK (CRUK) Cambridge Institute, University of Cambridge, Cambridge, UK. · Institute of Cancer Research, Sutton, London, UK. · University of East Anglia, Norwich, UK. · Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere and Tampere University Hospital, Tampere, Finland. · Johns Hopkins University, Baltimore, MD, USA. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · British Columbia Cancer Agency, Vancouver, Canada. · Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands. · Cancer Research Laboratory, University of Iceland, Reykjavik, Iceland. · School of Medicine, University of Queensland, Brisbane, Australia. · Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia. · UQ Centre for Clinical Research, University of Queensland, Brisbane, Australia. · Université Lyon 1, Institut National du Cancer (INCa)-Synergie, Lyon, France. · Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · Department of Radiation Oncology and Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands. · Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands. · Institut Bergonié, 229 cours de l'Argone, 33076 Bordeaux, France. · Institut Curie, Department of Tumor Biology, 26 rue d'Ulm, 75248 Paris cédex 05, France. · Translational Cancer Research Unit and Department of Pathology, GZA Hospitals, Antwerp, Belgium. · Royal National Orthopaedic Hospital, Middlesex, UK. · UCL Cancer Institute, University College London, London, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25082706
  • Cancer Genome Project, Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · Lungs for Living Research Centre, Rayne Institute, University College London, London WC1E 6JF, UK. · 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK [2] University of Cambridge, Cambridge CB2 0XY, UK. · Departments of Pathology and Oncology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA. · Addenbrooke's NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Children's Brain Tumour Research Centre, University of Nottingham, Nottingham NG7 2UH, UK. · Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada M5G 1X8. · Institute for Cancer Research, Sutton, London SM2 5NG, UK. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · 1] Lungs for Living Research Centre, Rayne Institute, University College London, London WC1E 6JF, UK [2] Royal National Orthopaedic Hospital, Middlesex HA7 4LP, UK. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia. · Department of Pathology, Memorial-Sloan-Kettering Cancer Center, New York, New York 10065, USA. · 1] Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia [2] Department of Gastroenterology, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria 3050, Australia. · National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27713, USA. · UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599, USA. · 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK [2] Addenbrooke's NHS Foundation Trust, Cambridge CB2 0QQ, UK. · 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK [2] University of Cambridge, Cambridge CB2 0XY, UK [3] Addenbrooke's NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Pubmed 24714652
2017
  • The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK; Department of Clinical Oncology, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. Electronic address: · Pubmed 28666921
2013
  • Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · Pubmed 23945592
Probable:    Guy's and St Thomas' NHS Trust      
2017
  • Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom. · Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London, United Kingdom. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 28572257
  • Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Big Data Institute, University of Oxford, Oxford OX3 7BN, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; European Bioinformatics Institute EMBL-EBI, Wellcome Genome Campus, Hinxton CB10 1SD, UK. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, USA; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, NM 87545, USA; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87102, USA. · The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Department of Human Genetics, University of Leuven, 3000 Leuven, Belgium. · Department of Pathology, Haukeland University Hospital, Bergen, Norway; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Computational Oncology, Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Institute, New York, NY 10065 USA. · Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK. · Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, 1000 Brussels, Belgium. · Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Department of Medical Oncology, Rotterdam, the Netherlands. · Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA; Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK; Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. Electronic address: · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. Electronic address: · Pubmed 28810143
  • Wellcome Trust Sanger Institute, Hinxton, UK. · Guy's and St Thomas' NHS Trust, London, UK. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. · Oncology, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Little Chesterford, UK. · Translational Research Lab Department, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics, Erasmus University Medical Center, Rotterdam, the Netherlands. · Centre for Clinical Research and School of Medicine, The University of Queensland, Brisbane, Queensland, Australia. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Department of Pathology, College of Medicine, Hanyang University, Seoul, Republic of Korea. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, UK. · Department of Molecular Biology, Faculties of Science and Medicine, Radboud University, Nijmegen, the Netherlands. · Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands. · Department of Cancer Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. · Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands. · Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. · Department of Pathology, Institut Curie, Paris, France. · INSERM U934, Institut Curie, Paris, France. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Now Research Unit, King's College, London, UK. · Breast Cancer Now Toby Robin's Research Centre, Institute of Cancer Research, London, UK. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · HistoGeneX, Wilrijk, Belgium. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, Montbonnot-Saint Martin, France. · Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Pubmed 28288110
2017
  • The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK; Department of Clinical Oncology, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. Electronic address: · Pubmed 28666921
Probable:    Wellcome Trust London      
2017
  • Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Big Data Institute, University of Oxford, Oxford OX3 7BN, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; European Bioinformatics Institute EMBL-EBI, Wellcome Genome Campus, Hinxton CB10 1SD, UK. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, USA; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, NM 87545, USA; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87102, USA. · The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Department of Human Genetics, University of Leuven, 3000 Leuven, Belgium. · Department of Pathology, Haukeland University Hospital, Bergen, Norway; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Computational Oncology, Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Institute, New York, NY 10065 USA. · Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK. · Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, 1000 Brussels, Belgium. · Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Department of Medical Oncology, Rotterdam, the Netherlands. · Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA; Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK; Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. Electronic address: · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. Electronic address: · Pubmed 28810143
2017
  • The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK; Department of Clinical Oncology, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. Electronic address: · Pubmed 28666921
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 11 total) written by Lucy R. Yates about Breast Neoplasms:

  • Translational Genomics: Practical Applications of the Genomic Revolution in Breast Cancer. 2017
  • Intratumoral heterogeneity and subclonal diversification of early breast cancer. 2017
  • Genomic Evolution of Breast Cancer Metastasis and Relapse. 2017
  • HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. 2017
  • Catalog of genetic progression of human cancers: breast cancer. 2016
  • Landscape of somatic mutations in 560 breast cancer whole-genome sequences. 2016
  • Subclonal diversification of primary breast cancer revealed by multiregion sequencing. 2015
  • Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. 2015
  • Mobile DNA in cancer. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. 2014
  • Processed pseudogenes acquired somatically during cancer development. 2014
Show List of Full Article Records
Google Searches

Learn more about Lucy R. Yates using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Wellcome Trust Sanger Institute
Guy's and St Thomas' NHS Trust
Wellcome Trust London
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Wellcome Trust Sanger Institute
2017
  • Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom. · Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London, United Kingdom. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 28572257
  • Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Big Data Institute, University of Oxford, Oxford OX3 7BN, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; European Bioinformatics Institute EMBL-EBI, Wellcome Genome Campus, Hinxton CB10 1SD, UK. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, USA; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, NM 87545, USA; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87102, USA. · The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Department of Human Genetics, University of Leuven, 3000 Leuven, Belgium. · Department of Pathology, Haukeland University Hospital, Bergen, Norway; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Computational Oncology, Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Institute, New York, NY 10065 USA. · Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK. · Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, 1000 Brussels, Belgium. · Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Department of Medical Oncology, Rotterdam, the Netherlands. · Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA; Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK; Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. Electronic address: · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. Electronic address: · Pubmed 28810143
  • Wellcome Trust Sanger Institute, Hinxton, UK. · Guy's and St Thomas' NHS Trust, London, UK. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. · Oncology, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Little Chesterford, UK. · Translational Research Lab Department, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics, Erasmus University Medical Center, Rotterdam, the Netherlands. · Centre for Clinical Research and School of Medicine, The University of Queensland, Brisbane, Queensland, Australia. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Department of Pathology, College of Medicine, Hanyang University, Seoul, Republic of Korea. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, UK. · Department of Molecular Biology, Faculties of Science and Medicine, Radboud University, Nijmegen, the Netherlands. · Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands. · Department of Cancer Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. · Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands. · Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. · Department of Pathology, Institut Curie, Paris, France. · INSERM U934, Institut Curie, Paris, France. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Now Research Unit, King's College, London, UK. · Breast Cancer Now Toby Robin's Research Centre, Institute of Cancer Research, London, UK. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · HistoGeneX, Wilrijk, Belgium. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, Montbonnot-Saint Martin, France. · Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Pubmed 28288110
2016
  • J.-C. Heuson Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Boulevard de Waterloo 121, 1000, Brussels, Belgium. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, CB10 1SA, UK. · 2nd Department of Pathology, Semmelweis University, Budapest, Hungary. · Pubmed 26951551
  • Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, UK. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 9NB, UK. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund SE-223 81, Sweden. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, New Mexico, USA. · Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Department of Human Genetics, University of Leuven, B-3000 Leuven, Belgium. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Rotterdam 3015CN, The Netherlands. · Radboud University, Department of Molecular Biology, Faculty of Science, 6525GA Nijmegen, The Netherlands. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge CB10 1SD, UK. · Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo 0310, Norway. · K. G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo 0310, Norway. · Department of Computer Science, University of Oslo, Oslo, Norway. · Gachon Institute of Genome Medicine and Science, Gachon University Gil Medical Center, Incheon, South Korea. · Translational Research Lab, Centre Léon Bérard, 28, rue Laënnec, 69373 Lyon Cedex 08, France. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, B-1000 Brussels, Belgium. · Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. · Department of Pathology, Asan Medical Center, College of Medicine, Ulsan University, Ulsan, South Korea. · Department of Pathology, College of Medicine, Hanyang University, Seoul 133-791, South Korea. · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA. · Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard., Houston, Texas 77030, USA. · Institute for Bioengineering and Biopharmaceutical Research (IBBR), Hanyang University, Seoul, South Korea. · Institut National du Cancer, Research Division, Clinical Research Department, 52 avenue Morizet, 92513 Boulogne-Billancourt, France. · University Hospital of Minjoz, INSERM UMR 1098, Bd Fleming, Besançon 25000, France. · Pathology Department, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. · Oncologie Sénologie, ICM Institut Régional du Cancer, Montpellier, France. · The University of Queensland, UQ Centre for Clinical Research and School of Medicine, Brisbane, Queensland 4029, Australia. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. · IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy. · Department of Pathology, Centre Léon Bérard, 28 rue Laënnec, 69373 Lyon Cédex 08, France. · Department of Pathology, GZA Hospitals Sint-Augustinus, Antwerp, Belgium. · Institut Curie, Paris Sciences Lettres University, Department of Pathology and INSERM U934, 26 rue d'Ulm, 75248 Paris Cedex 05, France. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK. · Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London SW3 6JB, UK. · Department of Clinical Science, University of Bergen, 5020 Bergen, Norway. · Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway. · National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore. · Singapore General Hospital, Outram Road, 169608, Singapore. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, 655, Avenue de l'Europe, 38330 Montbonnot-Saint Martin, France. · Synergie Lyon Cancer, Centre Léon Bérard, 28 rue Laënnec, Lyon Cedex 08, France. · Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, Texas 77230, USA. · Department of Radiation Oncology, Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen 6525GA, The Netherlands. · Pathology Queensland, The Royal Brisbane and Women's Hospital, Brisbane, Queensland 4029, Australia. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA. · Pubmed 27135926
2015
  • 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. [2] Department of Oncology, The University of Cambridge, Cambridge, UK. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. · 1] Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway. [2] Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. [2] Department of Human Genetics, University of Leuven, Leuven, Belgium. · Department of Surgery, Haukeland University Hospital, Bergen, Norway. · 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. [2] Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA. · Department of Pathology, Haukeland University Hospital, Bergen, Norway. · 1] Department of Pathology, Haukeland University Hospital, Bergen, Norway. [2] The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · 1] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 26099045
  • Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom; · Cytogenetics Facility, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom; · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom; Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, United Kingdom; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, United Kingdom; · Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, United Kingdom; Department of Haematology, University of Cambridge, Cambridge CB2 0XY, United Kingdom; · Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, United Kingdom; Cancer Research UK (CRUK) Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, United Kingdom; · BioCare, Strategic Cancer Research Program, SE-223 81 Lund, Sweden; CREATE Health, Strategic Centre for Translational Cancer Research, SE-221 00 Lund, Sweden; Department of Oncology and Pathology, Lund University Cancer Center, SE-221 85 Lund, Sweden; · Breakthrough Breast Cancer Research Unit, Research Oncology, King's College London, Guy's Hospital, London SE1 9RT, United Kingdom; · Laboratory for International Alliance on Genomic Research, RIKEN Center for Integrative Medical Sciences, 230-0045 Yokohama, Japan; National Center for Genome Medicine, Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan; · Department of Laboratory Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California 94158, USA; Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands; · Department of General Surgery, Singapore General Hospital, Singapore 169608; · Department of Molecular Oncology, British Columbia Cancer Agency, Vancouver V5Z 1L3, Canada; · Department of Radiation Oncology and Department of Laboratory Medicine, Radboud University Medical Center, 6525 HP Nijmegen, Netherlands; · Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 CE Rotterdam, Netherlands; · Section of Oncology, Department of Clinical Science, University of Bergen, N-5020 Bergen, Norway; Department of Oncology, Haukeland University Hospital, 5021 Bergen, Norway; · Institut Curie, INSERM U934 and Department of Tumor Biology, 75248 Paris cédex 05, France; · Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, 0450 Oslo, Norway; · Cancer Research Laboratory, University of Iceland, 101 Reykjavik, Iceland; · Royal National Orthopaedic Hospital, Middlesex HA7 4LP, United Kingdom; UCL Cancer Institute, University College London, London WC1E 6DD, United Kingdom; · University of Liverpool and HCA Pathology Laboratories, London WC1E 6JA, United Kingdom; · Urological Research Laboratory, Cancer Research UK Cambridge Research Institute, Cambridge CB2 0RE, United Kingdom; Department of Surgical Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 0QQ, United Kingdom; · Institute of Cancer Research, Sutton, London SM2 5NG, United Kingdom; Department of Biological Sciences and School of Medicine, University of East Anglia, Norwich NR4 7TJ, United Kingdom; · Division of Genetics and Epidemiology, The Institute of Cancer Research, Sutton SM2 5NG, United Kingdom; Royal Marsden NHS Foundation Trust, London SW3 6JJ and Sutton SM2 5PT, United Kingdom; · University of Queensland, School of Medicine, Brisbane, QLD 4006, Australia; Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, QLD 4029, Australia; University of Queensland, UQ Centre for Clinical Research, Brisbane, QLD 4029, Australia; · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, 1000 Brussels, Belgium; · Université Lyon 1, Institut National du Cancer (INCa)-Synergie, 69008 Lyon, France; · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA; · Department of Pathology, Ninewells Hospital and Medical School, Dundee DD1 9SY, United Kingdom; · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 25963125
2014
  • Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK. · Department of Physiology, School of Medicine-Center for Resesarch in Molecular Medicine and Chronic Diseases, Instituto de Investigaciones Sanitarias, University of Santiago de Compostela, Spain. · Lungs for Living Research Centre, Rayne Institute, University College London (UCL), London, UK. · Department of Clinical Science, University of Bergen, Bergen, Norway. · Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Human Genome Laboratory, Department of Human Genetics, VIB and KU Leuven, Leuven, Belgium. · Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Haematology, University of Cambridge, Cambridge, UK. · University of Liverpool and HCA Pathology Laboratories, London, UK. · Cancer Research UK (CRUK) Cambridge Institute, University of Cambridge, Cambridge, UK. · Institute of Cancer Research, Sutton, London, UK. · University of East Anglia, Norwich, UK. · Institute of Biosciences and Medical Technology-BioMediTech, University of Tampere and Tampere University Hospital, Tampere, Finland. · Johns Hopkins University, Baltimore, MD, USA. · Netherlands Cancer Institute, Amsterdam, Netherlands. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · British Columbia Cancer Agency, Vancouver, Canada. · Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands. · Cancer Research Laboratory, University of Iceland, Reykjavik, Iceland. · School of Medicine, University of Queensland, Brisbane, Australia. · Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Australia. · UQ Centre for Clinical Research, University of Queensland, Brisbane, Australia. · Université Lyon 1, Institut National du Cancer (INCa)-Synergie, Lyon, France. · Institute for Cancer Research, Oslo University Hospital, Oslo, Norway. · Department of Radiation Oncology and Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands. · Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, Netherlands. · Institut Bergonié, 229 cours de l'Argone, 33076 Bordeaux, France. · Institut Curie, Department of Tumor Biology, 26 rue d'Ulm, 75248 Paris cédex 05, France. · Translational Cancer Research Unit and Department of Pathology, GZA Hospitals, Antwerp, Belgium. · Royal National Orthopaedic Hospital, Middlesex, UK. · UCL Cancer Institute, University College London, London, UK. · MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 25082706
  • Cancer Genome Project, Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · Lungs for Living Research Centre, Rayne Institute, University College London, London WC1E 6JF, UK. · 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK [2] University of Cambridge, Cambridge CB2 0XY, UK. · Departments of Pathology and Oncology, Johns Hopkins Medical Institutions, Baltimore, Maryland 21205, USA. · Addenbrooke's NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Children's Brain Tumour Research Centre, University of Nottingham, Nottingham NG7 2UH, UK. · Department of Pediatrics, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada M5G 1X8. · Institute for Cancer Research, Sutton, London SM2 5NG, UK. · Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · 1] Lungs for Living Research Centre, Rayne Institute, University College London, London WC1E 6JF, UK [2] Royal National Orthopaedic Hospital, Middlesex HA7 4LP, UK. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia. · Department of Pathology, Memorial-Sloan-Kettering Cancer Center, New York, New York 10065, USA. · 1] Peter MacCallum Cancer Centre, Melbourne, Victoria 3002, Australia [2] Department of Gastroenterology, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria 3050, Australia. · National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27713, USA. · UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599, USA. · 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK [2] Addenbrooke's NHS Foundation Trust, Cambridge CB2 0QQ, UK. · 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK [2] University of Cambridge, Cambridge CB2 0XY, UK [3] Addenbrooke's NHS Foundation Trust, Cambridge CB2 0QQ, UK. · Pubmed 24714652
2017
  • The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK; Department of Clinical Oncology, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. Electronic address: · Pubmed 28666921
2013
  • Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK. · Pubmed 23945592
Guy's and St Thomas' NHS Trust
2017
  • Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, United Kingdom. · Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London, United Kingdom. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Pubmed 28572257
  • Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Big Data Institute, University of Oxford, Oxford OX3 7BN, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; European Bioinformatics Institute EMBL-EBI, Wellcome Genome Campus, Hinxton CB10 1SD, UK. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, USA; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, NM 87545, USA; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87102, USA. · The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Department of Human Genetics, University of Leuven, 3000 Leuven, Belgium. · Department of Pathology, Haukeland University Hospital, Bergen, Norway; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Computational Oncology, Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Institute, New York, NY 10065 USA. · Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK. · Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, 1000 Brussels, Belgium. · Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Department of Medical Oncology, Rotterdam, the Netherlands. · Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA; Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK; Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. Electronic address: · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. Electronic address: · Pubmed 28810143
  • Wellcome Trust Sanger Institute, Hinxton, UK. · Guy's and St Thomas' NHS Trust, London, UK. · Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden. · Oncology, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Little Chesterford, UK. · Translational Research Lab Department, Centre Léon Bérard, Lyon, France. · Department of Medical Oncology, Erasmus MC Cancer Institute and Cancer Genomics, Erasmus University Medical Center, Rotterdam, the Netherlands. · Centre for Clinical Research and School of Medicine, The University of Queensland, Brisbane, Queensland, Australia. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Cancer Research Laboratory, Faculty of Medicine, University of Iceland, Reykjavik, Iceland. · Department of Pathology, College of Medicine, Hanyang University, Seoul, Republic of Korea. · European Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Trust Genome Campus, Hinxton, UK. · Department of Molecular Biology, Faculties of Science and Medicine, Radboud University, Nijmegen, the Netherlands. · Department of Pathology, Academic Medical Center, Amsterdam, the Netherlands. · Department of Cancer Genetics, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. · K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, Norway. · Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, the Netherlands. · Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, the Netherlands. · Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. · Department of Pathology, Institut Curie, Paris, France. · INSERM U934, Institut Curie, Paris, France. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Brussels, Belgium. · Breast Cancer Now Research Unit, King's College, London, UK. · Breast Cancer Now Toby Robin's Research Centre, Institute of Cancer Research, London, UK. · Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Translational Cancer Research Unit, Center for Oncological Research, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. · HistoGeneX, Wilrijk, Belgium. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Equipe Erable, INRIA Grenoble-Rhône-Alpes, Montbonnot-Saint Martin, France. · Synergie Lyon Cancer, Centre Léon Bérard, Lyon, France. · East Anglian Medical Genetics Service, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Pubmed 28288110
2017
  • The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK; Department of Clinical Oncology, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. Electronic address: · Pubmed 28666921
Wellcome Trust London
2017
  • Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Big Data Institute, University of Oxford, Oxford OX3 7BN, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; European Bioinformatics Institute EMBL-EBI, Wellcome Genome Campus, Hinxton CB10 1SD, UK. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. · Theoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, Los Alamos, NM 87545, USA; Center for Nonlinear Studies, Los Alamos National Laboratory, Los Alamos, NM 87545, USA; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87102, USA. · The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK; Department of Human Genetics, University of Leuven, 3000 Leuven, Belgium. · Department of Pathology, Haukeland University Hospital, Bergen, Norway; The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK; Computational Oncology, Epidemiology and Biostatistics Memorial Sloan Kettering Cancer Institute, New York, NY 10065 USA. · Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK. · Department of Clinical Oncology, Guys and St Thomas' NHS Trust, London SE1 9RT, UK; Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK. · Breast Cancer Translational Research Laboratory, Université Libre de Bruxelles, Institut Jules Bordet, Bd de Waterloo 121, 1000 Brussels, Belgium. · Erasmus MC Cancer Institute and Cancer Genomics Netherlands, Erasmus University Medical Center, Department of Medical Oncology, Rotterdam, the Netherlands. · Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA; Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Division of Cancer Studies, Faculty of Life Sciences and Medicine, King's College London, London SE1 9RT, UK; Breast Cancer Now Research Unit, King's College London, London SE1 9RT, UK; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London SW3 6JB, UK. · Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Oncology, Haukeland University Hospital, Bergen, Norway. Electronic address: · Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK. Electronic address: · Pubmed 28810143
2017
  • The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK; Department of Clinical Oncology, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. Electronic address: · Pubmed 28666921
University of Cambridge
2015
  • 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. [2] Department of Oncology, The University of Cambridge, Cambridge, UK. · Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. · 1] Section of Oncology, Department of Clinical Science, University of Bergen, Bergen, Norway. [2] Department of Oncology, Haukeland University Hospital, Bergen, Norway. · Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. [2] Department of Human Genetics, University of Leuven, Leuven, Belgium. · Department of Surgery, Haukeland University Hospital, Bergen, Norway. · 1] Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, UK. [2] Theoretical Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA. · Department of Pathology, Haukeland University Hospital, Bergen, Norway. · 1] Department of Pathology, Haukeland University Hospital, Bergen, Norway. [2] The Gade Laboratory for Pathology, Department of Clinical Medicine, University of Bergen, Bergen, Norway. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · 1] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [2] Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 26099045
University of London
2017
  • The Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, CB10 1SA, UK; Department of Clinical Oncology, St Thomas' Hospital, Westminster Bridge Road, London, SE1 7EH, UK. Electronic address: · Pubmed 28666921
Yearly article counts 00422210000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.